MKI67 and neutropenia: At our cancer institute, we analyzed patient age, tumor grading, HR status, Ki67, BMI, BSA, previous treatment with adjuvant therapy (chemo or hormone therapy), the number of treatment lines, neutropenia, the number of metastatic sites, and which organs were involved.